BCL2A1 and ovarian cancer: The results showed that the foci number of BCL2A1-expressing cells was increased by 1.4-fold (p = 0.01) in OVCA433 cells and 1.6-fold (p = 0.01) in A2780cp cells compared with that of the vector control cells, confirming that BCL2A1 enhanced the foci formation capacity of ovarian cancer cells (Figure 4E).